Details of the Drug
General Information of Drug (ID: DMST2LX)
| Drug Name |
2-(pyridin-2-yl)-1H-benzo[d]imidazol-5-amine
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
55396-63-9; CHEMBL199925; 2-(pyridin-2-yl)-1H-1,3-benzodiazol-5-amine; MLS000528495; 2-Pyridin-2-yl-1H-benzoimidazol-5-ylamine; 2-(pyridin-2-yl)-1H-benzo[d]imidazol-5-amine; ITFXYBZUPPBWEC-UHFFFAOYSA-N; SMR000121070; 2-pyridin-2-yl-3H-benzimidazol-5-amine; 1H-Benzimidazol-5-amine, 2-(2-pyridinyl)-; 2-(Pyridin-2-yl)-1H-1,3-benzodiazol-6-amine; AC1LBVAV; 1H-Benzimidazol-6-amine, 2-(2-pyridinyl)-; AC1Q52EP; SCHEMBL8556415; SCHEMBL4371835; cid_542828; BDBM62926; CTK1F6864; DTXSID50337459; MolPort-006-709-925; MolPort-001-815-306
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 210.23 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.4 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


